Tumor-associated immune cells hinder frontline chemotherapy drug in pancreatic cancer
Researchers have shown how tumor-associated macrophages release compounds that block gemcitabine in the most common type of pancreatic cancerCredit: Leisa Thompson for the U-M Rogel...











